SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Shandong Boan Signs Japan License Deal for BA6101

Shandong Boan has signed a licensing agreement for its denosumab product BA6101 in Japan.

Related stories